Is this normal no scripts reported this week

[nylefty]

Aug 20, 2016 9:56:40 GMT -5 audiomr said:

This has happened before, and eventually it gets caught up. IMS and Symphony are subscription services, I believe, so the guy who maintains that list must know somebody who has access to the data. If either of those guys is unavailable on Friday, we don't get an update right away. Nothing to get worked up about.

The Symphony numbers have been available to anyone who had access to a Bloomberg terminal.  Ripano, who posts here, has such access but said yesterday that the Symphony numbers had not been posted. It's as simple as that.  As I said earlier, we used to have a source that had access to the IMS numbers, but moderator Liane said some time ago that she no longer had that source.

[gamblerjag]

  This might have been one of the times  (below two-fer) we didn't have the scripts info :    But now I'm starting to worry.  Von's didn't have my favorite Dole Juice..... I wonder if it's part of a bigger picture? 

We have a two-fer:

IMS data week ending 12/25/15

NRx = 207
TRx = 408

IMS data week ending 1/1/16

NRx = 220
TRx = 510


Read more: mnkd.proboards.com/thread/1742/afrezza-script-counts-symphony-data#ixzz4HtDxRjtH

[mannmade]

The good news is that TRx were up by 100. If that's the case it will be worth the wait for me this time.

[Deleted]

Aug 20, 2016 11:49:48 GMT -5 mannmade said:

The good news is that TRx were up by 100. If that's the case it will be worth the wait for me this time.

Holiday week and end of the year refill before new deductible sets in

[flatrock]

One thing that doesn't make sense to me is that someone said the CCO said he would provide prescription information, then someone else said he couldn't because of subscription restrictions, and then someone else said it was available on bloomberg terminals which I would think means it's pretty much public information anyway. So why is there so much confusion?

[Deleted]

Aug 20, 2016 13:41:14 GMT -5 flatrock said:

One thing that doesn't make sense to me is that someone said the CCO said he would provide prescription information, then someone else said he couldn't because of subscription restrictions, and then someone else said it was available on bloomberg terminals which I would think means it's pretty much public information anyway. So why is there so much confusion?

Cos intelligence levels vary. The primary source is Bloomberg terminal which gets data from Symphony

[nylefty]

Aug 20, 2016 13:41:14 GMT -5 flatrock said:

One thing that doesn't make sense to me is that someone said the CCO said he would provide prescription information, then someone else said he couldn't because of subscription restrictions, and then someone else said it was available on bloomberg terminals which I would think means it's pretty much public information anyway. So why is there so much confusion?

The prescription information on Bloomberg terminals isn't "pretty much public information."  Symphony charges big bucks for its numbers and to access them on Bloomberg you have to pay a minimum of $25,000 a year for one terminal.

If the Rx information was "public," Symphony and Bloomberg couldn't charge so much for it.  It's that simple. 

[flatrock]

Aug 20, 2016 13:57:35 GMT -5 nylefty said:

Aug 20, 2016 13:41:14 GMT -5 flatrock said:

One thing that doesn't make sense to me is that someone said the CCO said he would provide prescription information, then someone else said he couldn't because of subscription restrictions, and then someone else said it was available on bloomberg terminals which I would think means it's pretty much public information anyway. So why is there so much confusion?

The prescription information on Bloomberg terminals isn't "pretty much public information."  Symphony charges big bucks for its numbers and to access them on Bloomberg you have to pay a minimum of $25,000 a year for one terminal.

If the Rx information was "public," Symphony and Bloomberg couldn't charge so much for it.  It's that simple. 

I understand, but I doubt either symphony or bloomberg make much attempt to trace "leaks" and it seems like there should be a lot of bloomberg terminals available. It doesn't seem like it would be all that hard to find some analyst to peek at MNKD's numbers.

[nylefty]

Aug 20, 2016 15:13:16 GMT -5 flatrock said:

Aug 20, 2016 13:57:35 GMT -5 nylefty said:

The prescription information on Bloomberg terminals isn't "pretty much public information."  Symphony charges big bucks for its numbers and to access them on Bloomberg you have to pay a minimum of $25,000 a year for one terminal.

If the Rx information was "public," Symphony and Bloomberg couldn't charge so much for it.  It's that simple. 

I understand, but I doubt either symphony or bloomberg make much attempt to trace "leaks" and it seems like there should be a lot of bloomberg terminals available. It doesn't seem like it would be all that hard to find some analyst to peek at MNKD's numbers.

It isn't hard to find someone with access -- Ripano leaks the numbers every Friday.  But yesterday there were no numbers to leak.

[sportsrancho]

[flatrock]

Aug 20, 2016 17:29:10 GMT -5 sportsrancho said:

Thanks. Even more confused now. Why hasn't MNKD been the one releasing the data all along?

[mannmade]

Am curious about decline in TRx as that should be going up as well. I wonder if it is an insurance issue vs user satisfaction. And can mnkd track non renewal persons to get feedback?

[nylefty]

Aug 20, 2016 17:29:10 GMT -5 sportsrancho said:

New scripts in the past four reporting weeks: 483
New scripts in the preceding four weeks:  378

That's a 28 percent increase.  I'll take it. 

[mnkdorbust]

Aug 20, 2016 17:56:51 GMT -5 mannmade said:

Am curious about decline in TRx as that should be going up as well. I wonder if it is an insurance issue vs user satisfaction. And can mnkd track non renewal persons to get feedback?

Could it have anything to do with the new pack sizes?  Probably to early for that yet but curious as well.  

[slugworth008]